Lipella Pharmaceuticals Inc LIPO
We take great care to ensure that the data presented and summarized in this overview for LIPELLA PHARMACEUTICALS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in LIPO
Top Purchases
Top Sells
About LIPO
Insider Transactions at LIPO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2024
|
Jonathan H Kaufman Director |
BUY
Open market or private purchase
|
Direct |
10,000
+1.1%
|
$0
$0.76 P/Share
|
|
Mar 19
2024
|
Jonathan H Kaufman Director |
BUY
Open market or private purchase
|
Direct |
25,000
+2.74%
|
$0
$0.87 P/Share
|
|
Mar 18
2024
|
Jonathan H Kaufman Director |
BUY
Open market or private purchase
|
Direct |
30,000
+3.36%
|
$0
$0.79 P/Share
|
|
Mar 13
2024
|
Jonathan H Kaufman Director |
BUY
Grant, award, or other acquisition
|
Direct |
144,906
+14.81%
|
$0
$0.69 P/Share
|
|
Mar 13
2024
|
Michael B Chancellor Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
144,906
+14.17%
|
$0
$0.69 P/Share
|
|
Dec 22
2022
|
Michael B Chancellor Chief Medical Officer |
BUY
Other acquisition or disposition
|
Direct |
22,950
+3.04%
|
$114,750
$5.75 P/Share
|
Last 12 Months Summary
Buy / Acquisition
355K
Shares
From
3
Insiders
| Grant, award, or other acquisition | 290K shares |
|---|---|
| Open market or private purchase | 65K shares |
Sell / Disposition
0
Shares
From
0
Insiders